The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.

The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure. Cardiovasc Res. 2022 05 06; 118(6):1466-1478.

View in: PubMed

subject areas

Arrhythmias, Cardiac
Arrhythmogenic Right Ventricular Dysplasia
Cardiomyopathies
Death, Sudden, Cardiac
E1A-Associated p300 Protein
Heart Failure
Humans
Mechanotransduction, Cellular
Tumor Suppressor Protein p53
Wnt Signaling Pathway

authors with profiles

CRISTIAN COARFA
ALI MARIAN